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Abstract 
 
Background: Biofilm management and infection control are essential after periodontal and 
implant surgery. In this context, chlorhexidine (CHX) mouth-rinses are frequently recommended 
post-surgically. Despite its common use and many studies in this field, a systematic evaluation 
of the benefits after periodontal or implant surgery is – surprisingly - still missing. 
Objectives: To evaluate the benefits of chlorhexidine rinsing after periodontal or implant surgery 
in terms of plaque and inflammation reduction potential. Furthermore, to screen whether the 
concentration changes or additives in CHX solutions reduce side effects associated with its use.  
Materials and Methods: A systematic literature search was performed for clinical trials, which 
compared CHX rinsing after periodontal or implant surgery with rinsing using a placebo, non-
staining formulations or solutions with reduced concentrations of the active compound. Four 
databases (Medline, Pubmed, Embase, Cochrane) were searched up to June 2018. Two 
reviewers independently identified and screened the literature.  
Results: From 691 titles identified, only eleven publications met the inclusion criteria and were 
finally included. Mainly early publications assessed the benefits of CHX over placebo rinsing, 
whereas more recent publications focused more on the evaluation of new formulations with 
regard to effectiveness and side effects. The use of CHX after surgery showed in general 
significant reduction in plaque (means of 29-86% after 1 week) and bleeding (up to 73%) as 
compared to placebo. No consensus, however, was found regarding the most beneficial CHX 
formulation avoiding side-effects.  
Conclusion: Chlorhexidine rinsing helps to reduce biofilm formation and gingival inflammation 
after surgery. However, no additional reduction of PPD over any given placebo or control 
solution could be found irrespective whether CHX was used or not. The use of additives such as 
anti-discoloration systems (ADS) or herbal extracts may reduce side effects while retaining 
efficacy.  
Clinical relevance: Within the limitations of this review, it can be concluded that CHX may 
represents a valuable chemo-preventive tool immediately after surgery, during the time period in 
which oral hygiene capacity is compromised. To reduce the side effects of CHX and maintain 
comparable clinical effects, rinsing with less concentrated formulations (e.g. 0.12%) showed the 
most promising results so far.  
 
Keywords: Chlorhexidine - Periodontitis – Dental implant – Mouthwashes    
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Introduction 
 
Oral biofilms are the main etiologic factor for the development of periodontitis and peri-implantitis 
[1]. In addition, wound healing after periodontal and implant surgery may be negatively affected 
by the presence of such biofilms [1]. Hence, a reduction or better elimination of biofilm is 
essential for restoring gingival tissues to a healthy state [1]. Especially after surgical 
interventions, plaque control by mechanical means is restricted and therefore must be achieved 
using other measures, such as antimicrobial strategies [2]. In this regard, chlorhexidine (CHX) 
has historically taken a key role in chemical biofilm control. It is a cationic bisbiguanide and has 
frequently been used in general medicine as a broad-spectrum antiseptic since 1953 [3]. It has 
proven to be an efficient agent against oral biofilms as well and displays antimicrobial activity 
against gram-positive and -negative bacteria, yeasts, and viruses, including human 
immunodeficiency virus (HIV) and hepatitis B virus [4]. The effect is dose-dependent. Whereas 
CHX is bacteriostatic at low concentrations, higher concentrations also exhibit a bactericidal 
effect [5,6]. CHX has been shown to penetrate biofilms as well, altering biofilm formation or 
having a direct bactericidal effect [7,8]. The mode of action is explained as follows: As the 
bacterial cell is negatively charged, the cationic CHX-molecule binds to the cell surface. The 
integrity of the bacterial cell is thereby altered in such a way that CHX can penetrate the inner 
cell membrane leading to a higher permeability. This results in leakage phenomena of low-
molecular-weight components. At this point, the antimicrobial action is still at the bacteriostatic 
stage and can still be reversed if CHX is removed and the bacterial cell can recover. Stable or 
increasing CHX concentrations, however can lead to irreversible cell damage, i.e. cytoplasm 
coagulation and precipitation due to the formation of phosphate complexes such as adenosine 
triphosphate and nucleic acids [3,9]. 
Due to mostly negatively charged oral surfaces like teeth or the mucosa, CHX molecules display 
good adherence to these surfaces and thereby interfere with bacterial adhesion [5,10-13]. 
Further, CHX interacts with salivary glycoproteins. After rinsing with CHX, the saliva has been 
shown to exhibit an antibacterial activity for approximately five hours [14,15]. In addition, it has 
been suggested that CHX interferes with glucan production [16]. CHX binding to oral soft tissues 
allows substantivity for up to 12 hours [3]. Based on this mode of action and these properties, 
CHX is frequently used as mouth-rinse. The pharmacokinetics are favorable, as it is easy to 
reach an effective dosage of the active agent. Noteworthy, a mouth-rinse can be used 
independently of the patient`s ability to brush his teeth and is further well accepted by patients. 
This makes it an ideal preventive measure after surgical interventions, especially when 
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mechanical cleaning, for instance, is not possible or in clinical situations, in which mechanical 
plaque and inflammation control may be difficult due to discomfort or postoperative pain. 
However, this chemical plaque control is conceived for use on a short-term basis [3]. 
The clinically applied CHX concentrations mostly vary between 0.1–0.2 % and allow for reaching 
the ideal dosage of 18–20 mg per application. To reach a 20 mg dose with a 0.2 % 
concentration, 10 mL of solution must be applied for at least 30 seconds; with a 0.12 % 
concentration, 15 mL of solution must be applied for 60 seconds [3,17,18]. 
A beneficial clinical effect can already be observed with dosages of 5–6 mg, whereas dosages 
than 20 mg have been shown not to necessarily increase the effect. No adverse microbiologic 
changes, such as the overgrowth of opportunistic strains, when observing long-term use, have 
been reported so far, irrespective of the concentration used [19-21]. However, side effects must 
be taken into consideration 18. In this context, temporary taste alteration [22,23], staining of 
teeth, mucosa and/or tongue [24] and increase in calculus formation [25] have frequently been 
described. Staining, however, remains the most common adverse side effect. The degree of 
staining seems to correlate with the frequency of consumption of chromogenic products such as 
coffee, tea, wine, and tobacco as well as with the concentration of CHX [26,27]. In recent years, 
research and development has focused on developing different methods to reduce staining while 
maintaining CHX efficacy. Recently mouth-rinses with lower concentrations and/or in 
combination with other ingredients such as herbal extracts or hyaluronic acid have been 
assessed in order to decrease such side effects [28-30]. A so-called anti-discoloration system 
(ADS) has also been implemented [31-34]. 
After periodontal and implant surgery, CHX mouth-rinses are most commonly prescribed. In 
2017 a systematic review found it to be the most frequently used antiseptic agent after surgical 
intervention [35].  
Despite the aforementioned disadvantages, chemical plaque control remains a must for most 
clinicians. An older study from Hemp et al. (1975), where gingival biopsies were taken at wound 
sites in dogs after plaque had been allowed to accumulate, showed a general increase in 
gingival inflammation [36]. 
 
Nevertheless, and surprisingly enough, only a few studies have evaluated the benefit of CHX-
rinsing after periodontal or implant surgery and to the best of our knowledge, no systematic 
evaluation has been performed so far. Furthermore, systematic studies have not yet screened 
for optimal concentrations or compositions, which should be used to achieve optimal clinical 
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results with the least possible side effects. Therefore, this systematic review aimed for the first 
time to evaluate the benefit of CHX after periodontal or implant surgery compared to rinsing with 
a placebo and second to discern the influence of different concentrations and formulations in 
terms of efficacy, side effects and patient acceptance. We hypothesized, as shown for gingivitis 
prophylaxis and non-surgical periodontal therapy [37, 38-44], that rinsing with CHX  
1) Results in less plaque formation and bleeding as compared to placebo control 
2) Novel formulations are able to reduce side effects while still being effective, i.e. are as 
effective in plaque and bleeding reduction as the respective control (standard CHX-formulation).  
 
 
Materials and Methods: 
Protocols 
A systematic literature search has been conducted and studies published from 1976 through 
June 2018 were included. 
The review was conducted according to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) criteria. (Fig.1) The research question was assessed using the 
population, intervention, comparison and outcomes (PICO) method.  
Two specific questions were addressed as follows according to the PICO principles:  
1. In patients undergoing periodontal or implant surgery (Population), does Chlorhexidine 
rinsing as post-treatment protocol (Intervention) have a beneficial effect on clinical 
periodontal parameters and healing (Outcome) compared to rinsing with placebo-solution 
(Control)?  
2. In patients undergoing periodontal or implant surgery (Population), does rinsing with 
reduced CHX-concentration or substitution by other adjuncts, as post-treatment protocol 
(Intervention) have the same beneficial effect on clinical periodontal parameters and 
healing with less adverse effects (Outcome) compared to rinsing with placebo-solution 
(Control)?  
 
Search strategy: 
 
The following databases were included: PubMed, MEDLINE, Embase and Cochrane library and 
the following MeSH terms were searched: 
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Population/Health condition: Periodontal OR Periodontitis OR Paradontitis OR Parodontitis 
OR peri-implant OR Periodontal Disease OR Periimplantitis 
Therapy: Surgery OR GBR/ Guided Bone Regeneration OR GTR OR Guided Tissue 
Regeneration OR OFD OR Open Flap Debridement OR Widman Flap OR Modified Widman 
Flap OR Recession Coverage OR Root Coverage OR Implant Placement OR Implant Surgery 
OR Tunnel Technique OR Apical Positioned Flap OR Coronal Advanced Flap OR Split Flap OR 
Papilla Preservation Flap OR Distal Wedge OR Root Resection OR Tunnel Preparation OR 
Gingivectomy OR Root section 
Mouth-rinse: Chlorhexidine OR Chlorhexidine Phosphanilate OR Chlorhexidine di-gluconate 
OR Chlorhexidine Gluconate OR Zinc-chlorhexidine OR CHX OR CHX Formulations 
 
Screening and selection: 
Two authors (A.S. and M.K.) independently searched and screened the publications by title and 
abstract. The inclusion and exclusion criteria for the studies were as follows: 
 
Inclusion criteria were: 
• Randomized Controlled Trials (RCTs) evaluating CHX-rinsing after periodontal or implant 
surgery 
• Control group using a placebo, nothing or a different CHX-formulation 
• Evaluation of efficacy (plaque and bleeding) and side-effects (staining) 
 
Exclusion criteria were: 
• In-vitro-studies 
• Animal studies 
• Non-RCT study designs  
 
Available titles and abstracts were collected and discussed before being finally included or 
excluded. Inter-examiner agreement of a Cohen’s kappa (K) of 0.6 was achieved after initial 
screening. Authors discussed discrepancies until reaching consent. If required, the senior author 
(PRS) was consulted.  
The articles finally selected were analyzed as full texts (Fig. 1).  
 
Studies were divided in two groups according to the type of question:  
1) Results for plaque formation and bleeding, as compared to placebo control 
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2) Novel formulations are able to reduce side effects while still being effective, i.e. are as 
affective in plaque and bleeding reduction as the respective control  
 
Data (plaque accumulation, bleeding on probing (BOP) and tooth-staining) was extracted by 
both reviewers separately. 
Assessing the data, it was noted that the various studies used different scales and indices. 
Therefore, the authors agreed that the data be converted into a common unit, using percentage 
measurements in order to compare and interpret the results more easily.  
 
 
Quality assessment 
Quality assessment of the RCT`s using the Oxford quality scoring system by two authors (A.S. 
and M.K., Table 1) [45]. The Oxford scale assesses independently the methodological quality of 
a clinical trial judging the effectiveness of blinding described, the description of the 
randomization and drop-outs. 
A score of between zero (very poor) and five (rigorous) scale is described. 
 
Included studies received a 3- to 5-point score (max. 5 points) with a mean of 4.18. All eleven 
studies described randomized studies; three of which were not explicitly described as double-
blinded [29, 30, 47] and three investigations were split-mouth trials [46, 47, 48]. 
In five trials, sample size calculation was performed and a statistical power of 80-85% could be 
reached [28,29,49,50,54]. 
A relatively low number of patients (9 to 53 patients) in some of the studies could be considered 
as a potential limitation of the results obtained.  
Noteworthy was that seven of the eleven publications explicitly reported that they had no conflict 
of interests [28, 29, 30, 49, 50, 54, 61], whereas four studies did not mention this aspect [1, 46, 
47, 48]. 
 
Outcome measures:  
The main focus of this study was to filter out the benefits of a prescripted Chlorhexdine rinsing 
solution after periodontal or implant surgery on evaluation parameters such as plaque-index (PI) 
and bleeding-on-probing (BOP). In addition, changes in staining were tested. These primary 
outcomes were illustrated in different tables. Secondary parameter outcomes such as 
periodontal probing depth (PPD) and patient acceptance were described narratively since the 
data was very heterogenous. 
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Results 
 
In this review, we evaluated the benefits of chlorhexidine rinsing after periodontal or implant 
surgery in terms of plaque and inflammation reduction potential as compared to a placebo 
(Table 2). Further, we screened whether concentration changes or additives in CHX solutions 
were able to reduce side effects. The results are presented separately in the following sections. 
 
CHX vs. Placebo 
 
Plaque 
A summary of the plaque reducing potential of chlorhexidine after surgery as compared to 
placebo is depicted in Table 3. All four studies [1,46,47,48] assess the plaque reduction after 
rinsing with CHX and employ a placebo mouth rinse for comparison. Although CHX rinses are of 
different concentrations and vary between 0.12% [46,47] and 0.2% [1,48], all studies reported 
significantly less plaque accumulation with use of the CHX rinses as compared to the placebo 
groups. The reduction potential after 1 week ranged from 29% [1] to 86% [47]. After 2 weeks, it 
ranged between 50.9% [1] and 82% [48]. 
 
Gingival parameters 
 
In terms of bleeding on probing (BOP) reduction, which was assessed in all four studies, the 
results ranged from 0% to 73% after 1 week (Table 4) [46,48]. Sanz et al. (1989) found that 
chlorhexidine led to a 16.8% and 10.3% reduction of gingivitis severity (average extent of the 
disease) after 4 and 6 weeks as compared to the control, respectively. With regard to gingival 
bleeding, CHX reduced the index score by about 40% after 4 and 6 weeks. 
For wound healing and epithelialization, no statistically significant differences could be found, 
although the CHX group showed consistently better epithelialization [1]. 
Regarding sulcus bleeding index, Newman & Addy and Vaughan & Garnick also found a high 
statistical difference when CHX was used after surgery, compared to the placebo rinse, however 
this difference was no longer present after 1 and 3 months, when routine oral hygiene was re-
instructed [46,47]. 
With regard to crevicular fluid flow rate during chlorhexidine-rinsing, no significant differences 
could be observed [47]. It was also found that CHX had no significant effect on the gingival 
inflammation parameters under periodontal dressings [48].  
 
Probing Pocket depth 
Two studies assessed the question, whether chlorhexidine rinsing could improve the clinical 
outcome after surgery as measured by periodontal pocket depth reduction resulting in a long-
term effect. Irrespective of whether a chlorhexidine rinse was used or not they found that there 
was no additional benefit [1,46]. Therefore, no beneficial long-term effect could be seen from 
postoperative administrated CHX over placebo rinsing. 
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Patient acceptance 
 
Overall patient compliance with CHX usage was not necessarily hindered by its side effects. 
CHX is known for several side effects, especially when used for longer periods. 
Three out of four studies reported on these parameters. On the development of post-surgical 
pain, patients reported no advantage when using CHX. Also, there was no difference in the 
amount of pain medication used [1,47]. 
As expected, significantly more staining (p = 0.017) after the use of chlorhexidine was described 
by one study [1], which supports prior findings [24]. 
In a questionnaire, 67% of the patients liked and 24% disliked the taste of CHX [1]. 
The amount of self-perceived swelling was found to be greater in the CHX group (p= 0.016) [47]. 
 
Novel chlorhexidine formulations 
 
CHX vs. alcohol-free CHX 
 
An overview of included publications assessing different CHX-formulations is provided in table 5.  
The comparison of alcohol-free with alcohol-based solutions was described in two studies 
[49,61]. Alcohol-free CHX solutions have been introduced in an attempt to lower side effects. 
Alcohol is basically used to dissolve other compounds in the solution, and an antiseptic effect 
has also been discussed.  
Olsson et al. 2012 carried out an RCT assessing the difference between alcohol-based CHX 
rinse and non-alcohol based CHX rinse on 20 patients after periodontal surgery. They did not 
find any significant differences in plaque-inhibition or amount of staining between the two 
solutions. This result agrees with findings of other non-surgical studies [49]. 
Both solutions were accepted equally well by the patients. Van Strydonck et al. reported, 
however, that patients preferred the taste of the alcohol-free CHX [50]. 
In 2018, Gkatzonis et al. conducted a study with 42 patients assessing the efficacy of both 
alcohol-based and alcohol-free solutions, as well as a third non-chlorhexidine solution (C31G). 
The trial resulted in significant superior plaque control of alcohol-based CHX over alcohol-free 
CHX and the third solution (p < 0.001). Despite showing no statistically significant differences in 
terms of post-surgical wound healing between the three solutions, it hints that the presence of 
alcohol may increase the efficacy of CHX in the early wound healing response (EHI = early 
wound healing index) [61].  
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CHX with ADS systems 
Due to its main side effect of staining, and with it the possibility of reduced compliance, CHX 
mouthrinses with additional anti-discoloration-system (ADS) have been introduced. The 
combination of CHX with metabisulphite, peroxiborate, polyvinyl porrylidone and ascorbic acid 
has been described to interfere with pigmentation processes. While some studies have shown 
the ADS does not interfere with the antiplaque capacity of CHX [33] others studies have shown 
the opposite, that the addition of these substances reducing the efficacy of CHX [51]. The 
staining incidence has been shown in some studies to be significantly lower than without these 
additives [52,53], while other studies did not show any statistical differences [33,50]. 
Two RCTs specifically dealing with the use of CHX with anti-discoloration-system (ADS) after 
periodontal surgery were identified. In 2008, Cortellini et al. compared a 0.2% CHX rinse with a 
0.2% CHX rinse with ADS. Bevilacqua et al. in 2016 additionally included 0.12% CHX in his 
comparative clinical trial. No differences could be found regarding efficacy of plaque inhibition 
and improvement of post-surgical healing in either study. In terms of staining, according to 
Cortellini et al. CHX with ADS showed clearly less pigmentations than the control CHX [50]. The 
CHX-solution with ADS was found to be better tolerated than the CHX without additives in both 
studies. Further it caused less alteration in food taste and salt perception than the control 
solution. Finally, the test CHX with ADS showed less irritation to the oral tissues. The adjunct of 
ADS could be of value after surgery where patient compliance is very important in terms of 
reducing microbial colonization in surgical sites. Bevilacqua et al. could not find any significant 
difference between the 0.2% CHX-, 0.2% with ADS- and 0.12%- groups tested regarding 
efficacy or staining [54]. 
 
Other CHX formulations 
Genovesi et al. 2015 conducted an RCT with 40 patients after implant surgery comparing a 0.12 
% CHX mouthwash to a 0.12% CHX plus hyaluronic acid mouthwash. The authors stated that 
hyaluronic acid in earlier studies seemed to be involved in the reduction of inflammation and in 
the promotion of re-epithelialization. The anti-oedematigenous effect of hyaluronic acid was 
confirmed in this study. Only 20% of patients treated with a hyaluronic acid additive showed 
edema, whereas 78% of the patient treated with only CHX showed edema at the surgical site 
after 2 days (p = 0.0009). In regards to anti-plaque and anti-gingivitis efficiency, no significant 
differences were noted by the authors. Further, both solutions showed no difference in the 
amount of staining produced [28]. 
Essential oils are known in medicine for their antimicrobial and anti-inflammatory properties. 
Gursoy et al. evaluated the effect of essential oils on periodontitis associated bacteria, 
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suggesting they inhibit growth of periodontitis-associated bacteria [55]. It was also demonstrated 
that plant extracts could inhibit the growth of oral biofilm similar to CHX.  
A research group in the periodontology department at the University of Bern conducted two trials 
comparing 0.1% CHX and 0.05% CHX with herbal extract added after periodontal and implant 
surgeries in 2010 and 2015, the results of which support the above-mentioned theories [29,30]. 
No statistical differences were found for early wound healing, the reduction of probing pocket 
depth and reduction of the subgingival bacteria between the two solutions. While in the herbal 
extract group in both trials significantly lower tooth staining was observed, it could not be 
completely avoided. Even the ability to actively facilitate stain removal by the herbal extracts was 
discussed. Further, patients in the test group reported less loss of taste. The authors concluded 
that the lower concentration of CHX enhanced with herbal extracts may bring a benefit 
comparable to regular CHX solutions for long-term application. 
 
 
Discussion 
 
Chlorhexidine remains a widely and routinely prescribed rinsing solution after periodontal or 
implant surgery despite known side effects and interactions with healing [3]. This systematic 
review assessed the benefits of CHX after periodontal or implant surgery for the major clinical 
surrogate parameters of plaque, gingival inflammation and bleeding as compared to rinsing with 
a placebo. Further, the influence of different concentrations and formulations in terms of efficacy, 
side effects and patient acceptance were evaluated as well.  
Eleven studies could be finally included in this review. Four studies compared the effect of CHX 
to a placebo solution whereas seven evaluated alternative CHX formulation in terms of clinical 
effectiveness and side effects. Despite the fact that CHX after surgery is part of the routine 
protocol employed in most practices, to the best of our knowledge, this review represents the 
first attempt to systematically assess the benefits of CHX-rinsing after periodontal or implant 
surgery. No systematic review has yet evaluated alternative CHX formulations in these 
indications as well. Systematic reviews on CHX in periodontology or implant dentistry have 
mainly focused on the benefits and risks after scaling and root planning to date [41,43]. 
Furthermore, only eleven clinical trials qualified for the inclusion in this review and evaluated 
post-surgical rinsing with CHX after periodontal or implant surgery and comparing this regimen 
with a placebo control. 
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It is well accepted, however, that rinsing with CHX after surgery represents a valuable adjunct in 
periodontal therapy in order to help patients reach a plaque-free or -reduced oral environment 
for optimized post-surgical healing, when mechanical cleaning at affected sites is not possible. 
Gartenmann et al. described Chlorhexidine as the most frequently used antiseptic agent used for 
2 weeks following periodontal intervention [35]. 
Therefore, the results of this review may not be completely surprising. A meta-analysis of trials 
assessing CHX use after conventional SRP showed a slight but significant improvement of 
clinical attachment level and probing depth for patients rinsing with CHX over patients using a 
placebo solution [41]. These results are only partly reflected with the findings after periodontal 
surgery mentioned in this evaluation, where no significant improvement in pocket probing depth 
were found [1,46]. Beiswanger et al. published a study showing a mean plaque-reduction of 54% 
two and four weeks after conventional SRP and CHX mouth rinsing [56]. These results are 
comparable to the findings described after surgery. In 2017, James et al. published a systematic 
review that included 51 trials, about the benefit of CHX on gingival health.57 An evaluation of the 
plaque indices in 12 different trials on 950 patients showed a large effect for CHX as compared 
to a placebo or no control rinse after 4 and 6 weeks. In terms of BOP/bleeding scores after initial 
SRP, a reduction of 48% in favor of CHX versus a placebo after two and four weeks was 
described previously [56]. In the review by James at al. the overall effect of CHX was judged as 
moderate (SMD -0.56) [57]. Results after surgery seem to be very similar, as found in the 
present review.  
In the second part of this review, attention was paid to studies, which aimed to maintain or 
improve the CHX efficacy, while lowering side effects, by modifying the formulation. It was not 
surprising that the main side effects of tooth-staining and taste alterations were mentioned in 
most studies evaluated. The addition of a so-called anti-discoloration system (ADS) lowering the 
CHX concentration or supplementation with herbal extracts were the main measures to 
counteract possible side-effects. In general, results for these additives were contradictory. In 
addition, a comparable antibacterial effect was also not consistently achieved.  
Regarding differences between alcohol- or water-based CHX formulations, the findings are 
inconsistant. While Olsson et al. state there are no differences regarding plaque control or 
wound healing [49], Gkatzonis et al. report a significant better plaque control by alcohol-based 
solutions [61]. Alcohol was not shown to alleviate the side-effects of CHX in the studies 
assessed. 
With respect to the CHX concentration, lower concentrations (0.12%) displayed a similar clinical 
effectivity as the 0.2% concentrated solution. However, a lower concentration seemed to reduce 
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side effects [29,30]. Lowering CHX concentration, in combination with herbal extract additives, 
might be a good approach as shown in the few studies. In some trials, herbal extracts have been 
compared to CHX solutions, whereby slight clinical benefits were found [58-60]. No in vivo trials 
could be found evaluating a mixed herbal/CHX solution, however. 
All RCTs reported clinical benefits when using CHX to prevent biofilm accumulation on non-
shedding tooth surfaces after surgery, which supports the finding of studies that evaluated CHX-
rinsing after initial SRP-treatment [47]. 
Additional trials are therefore still needed to definitively evaluate the benefits of rinsing with CHX 
after periodontal surgery or implant placement, as the number of clinical trials available are 
relatively small. This represents an essential limitation to our systematic review, despite the fact 
this topic is not at all new. Further, comparison of the results is difficult due to inconsistent 
outcome parameters and measurement techniques. Notably, different scales and indices were 
used in the various studies, despite the fact that most assessed comparable clinical situations 
and outcome parameters, i.e. plaque accumulation, gingival inflammation and wound healing. In 
addition, the observation periods varied widely between studies. A standardized comparison and 
meta-analysis was therefore not possible. Therefore, in order to identify an optimal spectrum of 
efficacy, with minimal side effects, additional clinical trials are still warranted. 
 
 
Conclusion 
 
Within the limitations of this systematic review, it can be concluded that CHX rinsing helps to 
reduce plaque accumulation and gingival inflammation after periodontal and implant surgery. On 
the short term, CHX is a valuable chemo-preventive tool, especially during the time period in 
which self-performed oral hygiene is compromised. However, as data from two studies (49 
patients) has shown, current rinsing concepts have no positive effect on long term PPD 
reduction when compared to a placebo solution. Further, data from seven studies (247 patients) 
provided comparable clinical results when patients rinsed with reduced CHX concentrations (e.g. 
0.12% vs 0.2%) in order to reduce side effects. 
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Tables 
 
Table 1 
Quality assessment via Oxford quality scoring system [45]. 
 
 Sanz et al. 1989 [1] 
Vaughan et al. 1989 
[47] 
Langenbaek 
1976 
[48]  
New
m
an et al. 1981 
[46] 
Cortellini et al. 2008 
[50] 
Bevilacqua et al. 2016 
[54] 
G
enovesi et al. 2015 
[28] 
O
lsson 
et 
al. 
2012 
[49] 
Duss et al. 2010 [29] 
Laugisch et al. 2015 
[30] 
G
katzonis et al. 2018 
[61] 
Described as 
randomized * 
1 Split-
mouth/1 
Split-
mouth/1 
Split-
mouth/1 
1 1 1 1 1 1 1 
Described as 
double-blind * 
1 0 1 1 1 1 1 1 0 0 1 
Randomization 
method 
described and 
appropriate ** 
1 Split-
mouth/1 
Split-
mouth/0 
Split-
mouth/1 
1 1 1 1 1 1 1 
Double-blinding 
method 
described and 
appropriate ** 
1 0 0 1 1 0 1 1 0 0 1 
Drop-outs justified 
* 
1 1 1 1 1 1 1 1 1 1 1 
SCORE 5 3 3 5 5 4 5 5 3 3 5 
*   A study receives a sore of 1 for “yes” and 0 for “no” 
** A study receives a sore of 0 if no description is given, 1 if the method is described 
and appropriate, -1 if the method is described is inappropriate 
 
 
  
Table 2. Overview of the included publications comparing CHX to placebo. 
 
 
 
  
Author Rinsing 
Agent 
Concentration Intervention 
& Duration 
Sample 
Size 
Follow-
up 
Evaluation Study 
Desig
n 
Sanz et al. 
1989 [1] 
CHX vs.  
Placebo 
0.12% Osseous 
periodontal 
surgery 
 
 
2x/d 30 sec. 
for 6 weeks  
40 1,2,4,6 
weeks 
• Plaque-Index 
• BOP 
• PPD 
• Epithelialization 
• Patients 
acceptance 
RCT 
Vaughan et 
al. 1989 [47] 
CHX vs.  
Placebo 
0.12% Open flap 
debridement 
 
 
2x/d for  
2 weeks 
9 1, 2 
weeks 
• Plaque-Index 
• BOP 
• Crevicular fluid 
flow 
• Pain/swelling 
RCT 
 
Cross-
over 
Langenbaek 
1976 [48] 
CHX vs.  
Placebo 
0.2% Gingivectomy 
 
2x/d for  
3 weeks 
24 1,2,3 
weeks 
• Plaque-Index 
• BOP 
 
RCT 
Newman et 
al. 1981 [46] 
CHX vs. 
Placebo 
(NaCl) 
0,2% Inverse bevel 
flap 
 
 
3x/d for  
1 week 
9 1 week, 
1 and 3 
months 
• Plaque-Index 
• BOP 
• PPD 
• Patients 
acceptance 
 
RCT 
 
Cross-
over 
Table 3. Reduction of plaque accumulation; CHX vs. Placebo. 
 
 
  
Author Rinsing 
Agent 
Concentration Follow-up Mean Plaque-Index- 
reduction of CHX vs. 
Placebo 
Significant 
reduction 
(overall) 
Sanz et al. 
1989 [1] 
CHX vs.  
Placebo 
0,12% 1 week 
 
2 weeks 
 
4 weeks 
 
6 weeks 
 
• 29% 
 
• 50.9% 
 
• 52.3% 
 
• 54.4% 
 
 
yes 
Vaughan et 
al. 1989 [47] 
CHX vs.  
Placebo 
0,12% 1 week 
 
2 weeks 
• 86%  
 
• 82%  
yes 
Langenbaek 
1976 [48] 
CHX vs.  
Placebo 
0.2% 
 
 
1 week 
 
2 weeks 
 
3 weeks 
 
• 63% 
 
• 57% 
 
•  49% 
yes 
Newman et 
al. 1981 [46] 
CHX vs. 
Placebo 
(NaCl) 
0,2% 1 week 
 
 
 
• 37% yes 
Table 4. Reduction of BOP; CHX vs. placebo 
 
 
 
Author Rinsing 
Agent 
Concentration Follow-up Mean BOP- reduction of 
CHX vs. Placebo 
Significant 
reduction 
(overall) 
Sanz et al. 
1989 [1] 
CHX vs.  
Placebo 
0.12%  
4 weeks 
 
6 weeks 
 
 
• 41.6% 
 
• 40% 
yes 
Vaughan et 
al. 1989 [47] 
CHX vs.  
Placebo 
0.12% 1 week 
 
 
2 weeks 
 
• 58%  
 
 
•  60%  
yes 
Langenbaek 
1976 [48] 
CHX vs.  
Placebo 
0.2% 
 
 
1 week 
 
2 weeks 
 
3 weeks 
 
• 0% 
 
• 10% 
 
• 16% 
yes 
Newman et 
al. 1981 [46] 
CHX vs. 
Placebo 
(NaCl) 
0.2% 1 week 
 
 
 
• 73% yes 
Table 5. Overview of included publications assessing the most beneficial CHX-formulation.  
Author Rinsing 
Agent 
Concentratio
n 
Intervention 
& Duration 
Patient 
No. 
Follow-
up 
Evaluation Study 
Design 
Cortellini et 
al. 2008 [50] 
CHX vs. 
CHX + 
ADS 
0.2% vs.  
0.2% + ADS 
Open flap 
debridement 
 
2x/d for 1 
week each  
(2 weeks) 
47 1, 2 
weeks 
• Gingival 
parameters 
• Staining 
• Patients 
acceptance 
Cross-
over 
RCT 
Bevilacqua et 
al. 2016 [54] 
CHX vs. 
CHX + 
ADS 
0.12% vs. 
0.2% vs.  
0.2% + ADS 
Open flap 
debridement 
 
1 week 
 
 
53 1, 2 
weeks 
• Plaque Index 
• BOP 
• Staining 
• Patients 
acceptance 
RCT 
Genovesi et 
al. 2015 
[28] 
CHX vs. 
CHX + 
hyaluro-
nic acid 
0.12% vs. 
0.12% + 0.1% 
hyaluronic acid 
Implant 
placement 
 
2x/d for 15 
days 
40 3h, 2d, 
15d 
• Plaque Index 
• BOP 
• Staining 
• Edema presence 
 
RCT 
Olsson et al. 
2012 
[49] 
CHX vs. 
alk-free 
CHX  
0.12% Open flap 
debridement 
 
2 weeks 
 
20 2, 4 
weeks 
• Plaque Index 
• Patients 
acceptance 
Cross-
over 
RCT 
 
Duss et al. 
2010 
[29] 
CHX vs. 
CHX + 
herbal 
extract 
0,1% CHX 
vs. 
0.05% CHX + 
herbal extract 
Open flap 
debridem-ent 
 
4 weeks 
45 2, 4, 12 
weeks 
• PPD 
• Staining 
• Bacteriological 
analysis 
RCT 
Laugisch et 
al. 2015 [30] 
CHX vs. 
CHX + 
herbal 
extract 
0,1% CHX 
vs. 
0.05% CHX + 
herbal extract 
 
Flap surgery 
for perio- 
treatment or 
Implant-
placement. 
 
2x/d for 2 
weeks 
40 1, 2 
weeks 
• Early wound 
healing 
• Staining 
• Patients 
acceptance 
RCT 
  
  
Gkatzonis et 
al. 2018 [61] 
CHX vs. 
alk-free 
CHX 
vs. 
C31G 
 
0.12% Open flap 
debridement 
42 1,2 weeks • Early wound 
healing 
• Plaque Index 
• Bacterial count 
RCT 
Table 6. Plaque reduction after use of the different rinses. 
 
 
 
 
 
  
Author Rinsing 
Agent 
Concentration Patient 
No. 
Follow-up Plaque-reduction 
compared to 
baseline 
Significant 
Difference 
Between 
Rinses 
Bevilacqua 
et al. 2016 
[54] 
CHX vs. 
CHX + 
ADS 
a. 0.12%  
 
b. 0.2%  
 
c. 0.2% + 
ADS 
53 1 week 
 
 
 
2 weeks 
 
 
 
a. 4.8% 
b. 3.9% 
c. 3.8% 
 
a. 3.7% 
b. 3.9% 
c. 1.2% 
No statistical 
difference 
Genovesi et 
al. 2015 [28] 
CHX vs. 
CHX + 
hyaluronic 
acid 
a. 0.12%  
 
b. 0.12% + 
0.1% 
hyaluronic 
acid 
40 2 weeks  
a. 16% 
b. 22% 
No statistical 
difference 
Olsson et al. 
2012 [49] 
CHX vs. 
alk.-free 
CHX  
a. 0,12% 
 
b. 0.12% 
without Alk. 
20 
 
2 weeks 
 
 
 
4 weeks 
 
 
no baseline score 
assessed 
No statistical 
difference 
Gkatzonis et 
al. 2018 [61] 
alk.-free 
CHX 
vs. CHX 
 
 
 
a. 0.12% 
 
b. 0.12% 
 
42 1 week 
 
 
2 weeks 
No baseline score 
assessed 
Statistical 
significant 
Table 7. Mean stain reduction; test rinses vs. control rinses. 
 
 
 
 
 
Author Rinsing 
Agent 
Concentration Patient 
No. 
Follow-up Mean reduction of 
staining in the test group 
Significant 
Reduction 
(overall) 
Cortellini et 
al. 2008 [50] 
CHX vs. 
CHX + 
ADS 
0.2% vs.  
0.2% + ADS 
47 1 week 
 
2 weeks 
 
• 52% 
 
• 37% 
yes 
Bevilacqua 
et al. 2016 
[46] 
CHX vs. 
CHX + 
ADS 
0.12% vs. 
0.2% vs.  
0.2% + ADS 
53 1, 2 weeks • No percentage 
value calculable 
no 
Genovesi et 
al. 2015 [28] 
CHX vs. 
CHX + 
hyaluroni
c acid 
0.12% vs. 
0.12% + 0.1% 
hyaluronic acid 
40 2 weeks • 12% no 
Duss et al. 
2010 [29] 
CHX vs. 
CHX + 
herbal 
extract 
0,1% CHX 
vs. 
0.05% CHX + 
herbal extract 
45 4 weeks • 21.1% yes 
Laugisch et 
al. 2015 [30] 
CHX vs. 
CHX + 
herbal 
extract 
0,1% CHX 
vs. 
0.05% CHX + 
herbal extract 
 
40 1 week 
 
 
2 weeks 
• 5% 
 
 
• 11% 
no 
